Guardant Health, Inc.
GH
$129.69
-$3.53-2.65%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 12.78% | -38.58% | 7.18% | -4.98% | 14.28% |
| Total Depreciation and Amortization | -6.05% | 6.82% | -6.31% | -1.90% | -2.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.84% | 17.11% | 2.47% | 9.31% | 17.24% |
| Change in Net Operating Assets | -172.07% | 1,128.38% | 84.49% | 13.27% | -724.08% |
| Cash from Operations | -148.83% | 25.53% | 41.26% | 3.83% | 2.83% |
| Capital Expenditure | 79.96% | -169.06% | -83.22% | -26.69% | 76.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 186.16% | -20,355.78% | 20.00% | -101.63% | 945.14% |
| Cash from Investing | 177.28% | -6,207.09% | -34.75% | -103.52% | 2,776.20% |
| Total Debt Issued | -- | 7,801.99% | 200.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.00% | 9,684.52% | -59.72% | 1,102.73% | -84.73% |
| Repurchase of Common Stock | -285.84% | -136.29% | 69.48% | 87.74% | -654.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 81.06% | -1,021.67% | -144.54% | 168.04% | -12,152.54% |
| Cash from Financing | -102.95% | 16,802.05% | 166.69% | 102.43% | -2,177.68% |
| Foreign Exchange rate Adjustments | 71.72% | -28.71% | -156.88% | 21.22% | 145.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 405.86% | -335.33% | 32.77% | -139.27% | 397.03% |